Fort Washington’s PharmaMetrics, the provider of managed markets contract operations, strategy, analysis, and software, has been acquired by Center City’s IntegriChain, writes Michelle Caffrey for Philadelphia Business Journal.
The acquisition represents IntegriChain’s first deal since a private equity firm from Silicon Valley bought out all of its outsider investors last year. The financial terms of the deal have not been disclosed.
According to Kevin Leininger, IntergiChain’s co-founder and CEO, the deal will make it possible for the company to “bring together disparate commercial data assets into one enrichment and analytics platform.”
IntergiChain, which focuses on helping life sciences companies manage their operations and data through the cloud, currently employs around 80 people. That number will grow to close to 110 once the acquisition of PharmaMetrics is finalized.
“With the addition of PharmaMetrics’ market access expertise and capabilities to the IntegriChain platform, we can widen our focus to deliver analytics and solutions that allow pharmaceutical companies to balance the cost and efficacy of their pharmacy network, patient services, and co-pay assistance strategies,” said Leininger.
The deal comes two years after IntegriChain moved into new and tech-friendly office in Center City to attract young, high-caliber tech talent to the company.
Read more about the acquisition at Philadelphia Business Journal by clicking here.